A Danish government agency has committed €2.47m to a resveratrol study that will investigate multiple metabolic syndrome endpoints for the antioxidant
The five-year, human research project is sponsored by the Danish Council for Strategic Research will be the longest ever completed to date using resveratrol and add to a growing body of work for the nutrient. Danish supplier Fluxome will provide the resveratrol extract.
The lead researcher is Dr Steen Bønløkke Pedersen from Aarhus University, who said the project would include a one year randomised double-blinded study.
“From animal studies it is known that resveratrol has strong anti-inflammatory effects,” Dr Pedersen said in a research summary. “However, any health promoting effect of resveratrol in humans is only very sparsely studied. The precise intra-cellular anti-inflammatory pathways of resveratrol will furthermore be studied in clinical trials and in cell culture systems. Finally, a consumer acceptance study is conducted to evaluate the acceptance of use of resveratrol as food additive, herbal medicine or as novel food.”
Read article
© Natural Factors. All rights reserved.